ORAL ABSTRACTS
25 - Mesenchymal Stem/Stromal Cells: MESENCURE: A PROFESSIONALIZED CELL THERAPY FOR ARDS REDUCED THE MORTALITY OF SEVERE COVID-19 PATIENTS BY 68% ACCORDING TO A RECENTLY CONCLUDED MULTI-CENTER, CONTROLLED PHASE II STUDY

https://doi.org/10.1016/S1465-3249(22)00134-7Get rights and content

References (0)

Cited by (0)

View full text